CLL

conference reporter

by Anthony R. Mato, MD, MSCE

Reviewing data from the 63rd ASH Annual Meeting and Exposition, Anthony R. Mato, MD, MSCE, comments on novel-novel combinations, such as ibrutinib ......READ MORE

conference reporter

by Matthew S. Davids, MD, MMSc

Comprehensive care in chronic lymphocytic leukemia (CLL) ranges from understanding the patient’s treatment preferences to counseling them on recomm......READ MORE

conference reporter

by Matthew S. Davids, MD, MMSc

Long-term data reported at the 63rd ASH Annual Meeting and Exposition reflected advancements in chronic lymphocytic leukemia (CLL), such as improve......READ MORE

conference reporter

by Jan A. Burger, MD, PhD

First-line treatment for chronic lymphocytic leukemia (CLL) was the focus of several presentations at the 63rd ASH Annual Meeting and Exposition. O......READ MORE

conference reporter

by Jan A. Burger, MD, PhD

At the 63rd ASH Annual Meeting and Exposition, updated long-term data were reported from several trials of preferred frontline therapies for chroni......READ MORE